We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+3.44%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$80.2B
AUM Growth
+$2.8B
Cap. Flow
+$296M
Cap. Flow %
0.37%
Top 10 Hldgs %
9.83%
Holding
4,048
New
499
Increased
1,419
Reduced
1,452
Closed
416

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$667M
2
NVDA icon
NVIDIA
NVDA
+$584M
3
COP icon
ConocoPhillips
COP
+$432M
4
AMZN icon
Amazon
AMZN
+$418M
5
JNJ icon
Johnson & Johnson
JNJ
+$377M

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$836M
2
META icon
Meta Platforms (Facebook)
META
+$525M
3
AAPL icon
Apple
AAPL
+$453M
4
CELG
Celgene Corp
CELG
+$349M
5
PFE icon
Pfizer
PFE
+$306M

Sector Composition

Rank Sector Weight
1 Technology 15.58%
2 Consumer Discretionary 13.65%
3 Healthcare 12.98%
4 Industrials 7.3%
5 Financials 7.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMRT
3526
DELISTED
Stein Mart Inc
SMRT
$70K ﹤0.01%
+81,538
New +$74.2K
TEN
3527
Tsakos Energy Navigation Ltd
TEN
$1.19B
$69K ﹤0.01%
+4,186
New +$67.3K
CPE
3528
DELISTED
Callon Petroleum Company
CPE
$69K ﹤0.01%
1,042
-255
-20% -$18.4K
ALDX icon
3529
Aldeyra Therapeutics
ALDX
$91.7M
$67K ﹤0.01%
+11,104
New +$83.6K
ORC
3530
Orchid Island Capital
ORC
$1.31B
$65K ﹤0.01%
+2,039
New +$66.2K
VSTM icon
3531
Verastem
VSTM
$532M
$62K ﹤0.01%
3,434
-3,287
-49% -$74.5K
ADXS
3532
DELISTED
Advaxis Inc
ADXS
$62K ﹤0.01%
29,600
+2,743
+10% +$8.69K
NETI
3533
DELISTED
Eneti Inc.
NETI
$60K ﹤0.01%
+1,412
New +$60.3K
ABEO icon
3534
Abeona Therapeutics
ABEO
$345M
$59K ﹤0.01%
+497
New +$83.3K
BTE icon
3535
Baytex Energy
BTE
$3.08B
$59K ﹤0.01%
+37,900
New +$68.8K
VIVS
3536
VivoSim Labs
VIVS
$1.46M
$59K ﹤0.01%
472
-2,705
-85% -$511K
CVRS
3537
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$58K ﹤0.01%
+19,377
New +$48.5K
NEOS
3538
DELISTED
Neos Therapeutics, Inc
NEOS
$57K ﹤0.01%
+43,906
New +$80.8K
BRACW
3539
DELISTED
Black Ridge Acquisition Corp. Warrant
BRACW
$57K ﹤0.01%
138,000
CLDX icon
3540
Celldex Therapeutics
CLDX
$2.77B
$53K ﹤0.01%
19,619
-86,062
-81% -$292K
GORO icon
3541
Goldgroup Mining Inc.
GORO
$151M
$53K ﹤0.01%
+15,613
New +$52.9K
FOMX
3542
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$52K ﹤0.01%
21,880
-1,979
-8% -$5.91K
AVDL
3543
DELISTED
Avadel Pharmaceuticals
AVDL
$50K ﹤0.01%
17,425
-16,470
-49% -$28.3K
NOK icon
3544
CALL
Nokia
NOK
$50.8B
$50K ﹤0.01%
+10,000
New +$52.6K
GPOR
3545
PUT
DELISTED
Gulfport Energy Corp.
GPOR
$49K ﹤0.01%
10,000
FRED
3546
DELISTED
Fred's Inc
FRED
$47K ﹤0.01%
95,261
-315,358
-77% -$305K
AHT
3547
Ashford Hospitality Trust
AHT
$21M
$45K ﹤0.01%
+15
New +$70.2K
CGEN icon
3548
Compugen
CGEN
$216M
$45K ﹤0.01%
+11,691
New +$41.4K
BW icon
3549
Babcock & Wilcox
BW
$1.43B
$43K ﹤0.01%
12,460
-487,554
-98% -$1.88M
LKSD
3550
DELISTED
LSC Communications, Inc.
LKSD
$43K ﹤0.01%
11,754
-302,711
-96% -$1.78M

Similar funds

D.E. Shaw & Co's Q2 2019 Portfolio in Review

As of Q2 2019, D.E. Shaw & Co held 4,048 positions worth $80.2B, up 3.6% from $77.4B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

D.E. Shaw & Co's Q2 2019 filing shows 499 new, 1,419 increased, 1,452 reduced and 416 closed positions. Its largest new stake was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M. The largest sale was Qualcomm, an estimated $836M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • D.E. Shaw & Co's largest Q2 2019 buy was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M.
  • D.E. Shaw & Co added most to Alibaba in Q2 2019, an estimated $667M increase.
  • D.E. Shaw & Co's biggest Q2 2019 reduction was Qualcomm, cutting an estimated $836M.
  • D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q2 2019, selling an estimated $42.7M.
  • D.E. Shaw & Co's ten largest holdings make up 9.8% of its $80.2B portfolio in Q2 2019.
  • D.E. Shaw & Co opened 499 new positions and closed 416 in Q2 2019.
  • D.E. Shaw & Co's portfolio value rose 3.6% quarter-over-quarter to $80.2B.

Based on D.E. Shaw & Co's 13F filing for Q2 2019, filed 14 Aug 2019.